Which has the lower trailing P/E, GSK or SNY?

GSK has the lower trailing P/E: GSK trades at 15.89 and SNY at 80.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GSK or SNY?

Over the past five years, SNY grew revenue faster — GSK at a 1.38% CAGR versus SNY at 4.96%.

Does GSK or SNY pay a bigger dividend?

GSK yields 3.61% and SNY yields 5.39% based on trailing dividends and the latest price.

Is GSK or SNY more profitable?

GSK runs the higher net margin — GSK at 14.52% versus SNY at 8.10%.

How have GSK and SNY total returns compared?

Over the past 10 years, GSK delivered 6.31% and SNY delivered 5.69% annualized total return. Past performance doesn't predict future results.

GSK plc (GSK) vs Sanofi (SNY)

A side-by-side comparison of GSK plc and Sanofi across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

GSK

GSK plc

$100.64B

$50.23HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

SNY

Sanofi

$107.40B

$44.73HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

Total return — GSK vs SNY

growth of $100 · dividends reinvested · last 10y

GSK +84.9% (+6.3%/yr)SNY +74.5% (+5.7%/yr)GSK compounded faster over this window

GSK SNY

GSK vs SNY: by the numbers

•SNY is the larger company ($107.40B vs $100.64B market cap).
•GSK trades at the lower trailing earnings multiple (15.89 vs 80.55 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 8.10% net margin).
•SNY grew revenue faster over the past five years (4.96% vs 1.38% CAGR).
•SNY pays the higher dividend yield (5.39% vs 3.61%).

Metrics side by side

Valuation

Metric	GSK	SNY
P/E ratio	15.89	80.55
Forward P/E	14.03	N/A
P/S ratio	2.30	1.89
P/B ratio	4.39	1.36
EV / EBITDA	8.20	10.17
FCF yield	9.14%	12.72%

Profitability

Metric	GSK	SNY
Gross margin	72.71%	73.01%
Operating margin	20.72%	14.74%
Net margin	14.52%	8.10%
ROE	27.67%	5.82%
ROIC	13.95%	5.42%

Dividends

Metric	GSK	SNY
Dividend yield	3.61%	5.39%
Payout ratio	47.89%	64.36%

Growth (annualized)

Metric	GSK	SNY
Revenue CAGR (5Y)	1.38%	4.96%
EPS CAGR (5Y)	-0.71%	-8.92%
FCF CAGR (5Y)	-2.45%	12.83%
Total return CAGR (5Y)	8.59%	1.38%

Frequently asked

Which has the lower trailing P/E, GSK or SNY?: GSK has the lower trailing P/E: GSK trades at 15.89 and SNY at 80.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GSK or SNY?: Over the past five years, SNY grew revenue faster — GSK at a 1.38% CAGR versus SNY at 4.96%.
Does GSK or SNY pay a bigger dividend?: GSK yields 3.61% and SNY yields 5.39% based on trailing dividends and the latest price.
Is GSK or SNY more profitable?: GSK runs the higher net margin — GSK at 14.52% versus SNY at 8.10%.
How have GSK and SNY total returns compared?: Over the past 10 years, GSK delivered 6.31% and SNY delivered 5.69% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full SNY analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio Sanofi P/E ratio GSK dividend yield Sanofi dividend yield GSK ROE Sanofi ROE GSK operating margin Sanofi operating margin GSK revenue growth Sanofi revenue growth GSK free cash flow Sanofi free cash flow

GSK & Sanofi appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.